| 326 | 21 | 73 |
| 下载次数 | 被引频次 | 阅读次数 |
本研究通过对中国山西省2009~2015年哨点医院所采集的发热伴出疹症候群(Rash and fever syndrome,RFS)监测病例中六种病毒性病原体(麻疹病毒,风疹病毒,肠道病毒,水痘-带状疱疹病毒,人类小DNA病毒B19和登革病毒)进行描述性流行病学研究,阐明RFS在人群和时间的分布特点,揭示山西省2009~2015年RFS六种病毒病原谱构成及其流行规律,为山西省进一步开展RFS的预防和控制工作提供科学依据。在2009年1月1日至2015年12月31日期间,山西省共检测RFS监测病例846例,检出RFS病毒性病原阳性病例504例,阳性率为59.57%。其中麻疹病毒阳性192例(38.10%),肠道病毒阳性93例(18.45%),风疹病毒阳性87例(17.26%),水痘-带状疱疹病毒阳性83例(16.47%),人类小DNA病毒B19阳性48例(9.52%),登革病毒阳性1例(0.20%)。RFS阳性病例主要集中在15岁以下的儿童和学生,不同性别之间病原检出率无统计学差异,但不同年龄组的病原谱构成略有差异。RFS发病呈现出明显的季节性,38月为其发病高峰。监测数据提示我国应加强RFS系统性和连续性监测,将15岁以下的儿童和青少年作为重点监测人群,不同省份和地市可根据实际发病情况制定出具体的、有针对性的监测方案,以阐明本省或本地区RFS病毒病原的构成及其流行规律和疾病负担。
Abstract：A descriptive epidemiological study was done based on the surveillance data of rash and fever syndrome(RFS)in Shanxi Province,China,during 2009~2015. We analyzed the epidemiological characteristics and clarified the pathogenic spectrum of six viral pathogens among RFS cases:measles virus(MV),rubella virus(RV),enterovirus(EV),varicella zoster virus(VZV),human parvovirus virus B19(B19)and dengue virus(DENV).This strategy helped to provide a scientific basis for further prevention and control of RFS in Shanxi Province.From 1January 2009 to 31December 2015,846 RFS cases were detected in Shanxi Province.Among them,504 cases were identified as being virus-positive and the total prevalence of virus-positive was≤59.57%.The prevalence of positive cases was 192(38.1%)for MV,93(18.45%)for EV,87(17.26%)for RV,83(16.47%)for VZV,48(9.52%)for B19 and 1(0.20%)for DENV.Most RFS cases were concentrated in those under 15 years of age.There was no significant difference between the prevalence of virus-positive cases between males and females,but there was a slight difference in the pathogenic spectrum among the different age groups of RFS cases.The number of RFS cases reached a peak from March to August.Based on RFS surveillance data,RFS surveillance should focus on those aged <15years.Systematic and continuous surveillance of RFS is crucial to prevent and control RFS.Moreover,a specific surveillance program in different areas could illuminate the spectrum of viral pathogens,epidemiological features and burden of RFS.
[1]琚雄飞,许岸高,方巧云,黄娟媚.2010~2012年广东省发热伴出疹症候群的病原学研究[J].中华疾病控制杂志,2013(08):670-673.
[2]任晓卫,王新华,王玉.西北地区2009-2011年发热伴出疹症候群流行病学特征分析[J].中华疾病控制杂志,2012(10):913-914.
[3]中华人民共和国卫生部.艾滋病和病毒性肝炎等重大传染病防治科技重大专项传染病监测技术平台项目:发热伴出疹症候群监测实施方案[K].2008.
[4]WPRO.Measles Elimination in the Western Pacific Region[R].Manila,Philippines,2004-6-6.
[5]Ma C,Hao L,Zhang Y,Su Q,RodewaldL,AnZ,YuW,MaJ,WenN,WangH,LiangX,WangH,YangW,LiL,LuoH.Monitoring progress towards the elimination of measles in China:an analysis of measles surveillance data[J].Bull World Health Organ,2014,92(5):340-347.
[6]Edlich R F,Winters K L,Long W R,GublerK D.Rubella and congenital rubella(German measles)[J].J Long Term Eff Med Implants,2005,15(3):319-328.
[7]Zhu Z,Cui A,Wang H,ZhangY,Liu C,WangC,Zhou S,Chen X,Zhang Z,Feng D,Wang Y,Chen H,Pan Z,Zeng X,Zhou J,Wang S,Chang X,Lei Y,Tian H,Liu Y,Zhou S,Zhan J,Chen H,Gu S,Tian X,Liu J,Chen Y,Fu H,Yang X,Zheng H,Liu L,Zheng L,Gao H,He J,Sun L,Xu W.Emergence and continuous evolution of genotype 1Erubella viruses in China[J].J Clin Microbiol,2012,50(2):353-363.
[8]许文波,檀晓娟.手足口病:中国儿童传染病防控面临的新挑战[J].疾病监测,2009(09):649-651.
[9]赵奇,朱俊萍.中国手足口病的流行状况及病原谱变化分析[J].病毒学报,2015(05):554-559.
[10]Anderson M J,Jones S E,Fisher-Hoch S P,Lewis E,HallS M,BartlettC L,CohenB J,Mortimer P P,Pereira M S.Human parvovirus,the cause of erythema infectiosum(fifth disease)?[J].Lancet,1983,1(8338):1378.
[11]Lamont R F,Sobel J D,Vaisbuch E,KusanovicJ P,Mazaki-ToviS,KimS K,UldbjergN,RomeroR.Parvovirus B19infection in human pregnancy[J].BJOG,2011,118(2):175-186.
[12]孙秀侠,孙宝霞.育龄人群孕前强化麻疹疫苗对阻断“双相移位”的应用价值[J].中国医疗前沿,2013(05):111-112.
[13]马超,苏琪茹,郝利新,温宁,樊春祥,曹雷,张燕,王慧玲,罗会明,王华庆,李黎.中国2012~2013年麻疹流行病学特征与消除麻疹进展[J].中国疫苗和免疫,2014(03):193-199.
[14]Hersh B S,Tambini G,Nogueira A C,Carrasco P,de Quadros C A.Review of regional measles surveillance data in the Americas,1996-99[J].Lancet,2000,355(9219):1943-1948.
[15]M M,Ww W,Sc R.Measles among adults,United States,1985-1995.[J].1999,17(2):114-119.
[16]Recommendations for the production,control and regulation of human plasma for fractionation.WHO Technical Report Series No941,2007.
[17]FDA.Guidance for industry:nucleic acid testing(NAT)to reduce the possible risk of human parvovirus B19transmission by plasmaderived products,2009.http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm078510.pdf.
[18]Guideline on plasma-derived medicinal products.EMA/CHMP/BWP/706271/2010,2011.
[19]Human Plasma(Pooled and Treated for Virus Inactivation).European Phamarcopoeia 8.0,07/2013:1646:2426-2428.
[20]王永亮,李新民,郝宗宇,王俊杰.河南首次输入性登革热暴发流行控制的思考[J].河南预防医学杂志,2016(05):321-324.
[21]岳玉娟,吴海霞,李贵昌,刘起勇.2005-2013年中国大陆登革热病例空间分析[J].现代预防医学,2016(08):1345-1348.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.003117
中图分类号:R373
引用信息:
[1]邱琪,柴志凯,郜慧,等.2009～2015年中国山西省发热伴出疹症候群病毒性病原谱流行特征[J].病毒学报,2017,33(02):169-175.DOI:10.13242/j.cnki.bingduxuebao.003117.
基金信息:
“十一五”和“十二五”国家科技重大专项(项目号:2009ZX10004201,2009ZX10004202,2012ZX10004201,2013ZX10004202),题目:“艾滋病和病毒性肝炎等重大传染病防治”科技重大专项传染病监测技术平台项目
2017-03-29
2017-03-29
2017-03-29